Loading...

Hansoh Pharmaceutical Group Company Limited

3692.HKHKSE
HealthcareDrug Manufacturers - Specialty & Generic
HK$26.50
HK$0.50(1.92%)

Hansoh Pharmaceutical Group Company Limited 3692.HK Peers

See (3692.HK) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
3692.HKHK$26.50+1.92%157.6B33.13HK$0.80N/A
2196.HKHK$16.00+3.09%65.8B13.33HK$1.20+2.05%
0874.HKHK$17.72+2.19%46B9.79HK$1.81+7.80%
1513.HKHK$29.15+1.75%33.3B11.66HK$2.50+5.55%
3320.HKHK$5.17+2.17%32.5B8.91HK$0.58+6.12%
0512.HKHK$9.14+4.70%32B13.06HK$0.70+5.69%
3933.HKHK$15.34+7.57%27.9B9.65HK$1.59+4.01%
0867.HKHK$10.72+2.49%25.9B14.68HK$0.73+2.96%
0013.HKHK$23.20+7.41%20.2B74.84HK$0.31N/A
9989.HKHK$5.21+6.33%18.4B10.85HK$0.48+4.78%
Showing 1 to 10 of 42 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

3692.HK vs 2196.HK Comparison

3692.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3692.HK stands at 157.6B. In comparison, 2196.HK has a market cap of 65.8B. Regarding current trading prices, 3692.HK is priced at HK$26.50, while 2196.HK trades at HK$16.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3692.HK currently has a P/E ratio of 33.13, whereas 2196.HK's P/E ratio is 13.33. In terms of profitability, 3692.HK's ROE is +0.15%, compared to 2196.HK's ROE of +0.06%. Regarding short-term risk, 3692.HK is more volatile compared to 2196.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3692.HK.

Stock Price Comparison

Loading...

Frequently Asked Questions